The Effectiveness of Anti-Apoptotic Agents to Preserve Primordial Follicles and Prevent Tissue Damage during Ovarian Tissue Cryopreservation and Xenotransplantation
Open Access
- 3 March 2021
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (5) , 2534
Abstract
The purpose of this study is to investigate the effectiveness of sphingosine-1-phosphate (S1P) and Z-VAD-FMK (Z-VAD) as anti-apoptotic agents to preserve ovarian function and prevent tissue damage during ovarian tissue cryopreservation and transplantation. This study consisted of two steps, in vitro and in vivo. In the first step, human ovarian tissues were cryopreserved using slow-freezing media alone, S1P, or Z-VAD (control, S1P, Z-VAD group); based on the outcomes in these groups, Z-VAD was selected for subsequent xenotransplantation. In the second step, human frozen/thawed ovarian tissues were grafted into fifty mice divided into three groups: slow-freezing/thawing and transplantation without an anti-apoptotic agent (Trans-control) and xenotransplantation with or without Z-VAD injection (Trans-Z-VAD-positive and Trams-Z-VAD-negative groups, respectively). In the first step, the Z-VAD group had a significantly higher primordial follicular count than the S1P (p = 0.005) and control groups (p = 0.04). Transplanted ovarian tissues were obtained 4 weeks after transplantation (second step). Angiogenesis was significantly increased in the Z-VAD-negative (p = 0.03) and -positive (p = 0.04) groups compared to the control group. This study demonstrated that slow-freezing and transplantation with Z-VAD is an effective method for preserving primordial follicle counts, decreasing double-strand DNA breaks, and increasing angiogenesis in a mouse model. Further molecular and clinical studies are needed to confirm these results.Keywords
Funding Information
- The National Research Foundation of Korea Grant (NRF-2016R1C1B3015250)
This publication has 40 references indexed in Scilit:
- Antiapoptotic Agent Sphingosine-1-Phosphate Protects Vitrified Murine Ovarian GraftsReproductive Sciences, 2014
- Enhancement of Neoangiogenesis and Follicle Survival by Sphingosine-1-Phosphate in Human Ovarian Tissue XenotransplantsPLOS ONE, 2011
- Cryopreservation and Transplantation of Ovarian TissueClinical Obstetrics and Gynecology, 2010
- Both host and graft vessels contribute to revascularization of xenografted human ovarian tissue in a murine modelFertility and Sterility, 2010
- Is caspase inhibition a valid therapeutic strategy in cryopreservation of ovarian tissue?Journal of Assisted Reproduction and Genetics, 2009
- Electron paramagnetic resonance as a tool to evaluate human ovarian tissue reoxygenation after xenograftingFertility and Sterility, 2009
- Orthotopic and heterotopic ovarian tissue transplantationHuman Reproduction Update, 2009
- Radiosensitization of solid tumors by Z-VAD, a pan-caspase inhibitorMolecular Cancer Therapeutics, 2009
- Assessment of vascular endothelial growth factor expression and apoptosis in the ovarian graft: can exogenous gonadotropin promote angiogenesis after ovarian transplantation?Fertility and Sterility, 2008
- Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphateNature, 1996